SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-025055
Filing Date
2020-02-26
Accepted
2020-02-26 08:07:46
Documents
3
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm209689d1_8k.htm 8-K 21351
2 EXHIBIT 99.1 tm209689d1_ex99-1.htm EX-99.1 67816
3 GRAPHIC tm209689d1_ex99-1img001.jpg GRAPHIC 9088
  Complete submission text file 0001104659-20-025055.txt   102994
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 20653353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences